Journal rankings · indicator year 2024
Choose a field to open its ranking, or a journal to find its row in its subfield’s list.
Subfield ranking · 2024
Pharmacology journal rankings 2024
49 ranked journals · Subfield in Medicine
Pharmacology has 49 ranked journals in 2024. The median OJR rose 0.07 on 2023 to 0.72, below the world average of 1.00; Q1 starts at OJR 1.21. The top three are Natural Product Reports, Fungal Biology and Biotechnology, and Journal of Cannabis Research.
Ranks and citation indicators: 2024. Journal access status and listed APC: source snapshot September 23, 2026.
Journals whose main subfield sits in this category and that published at least 30 citable documents (articles, reviews and conference papers) in 2021–2023, the window the 2024 score is computed on.
The OpenJournalRank Indicator (OJR) is a free, publicly available metric of a journal’s field-normalized citation impact, computed from open OpenAlex citation data. It compares citations to a journal’s papers from the previous three years with the world average for papers of the same subfield, year and type, so 1.00 is the world average and values can be compared across fields. It is computed with the NCI3 method.
The middle OJR among ranked journals in this category: half score higher, half lower. 1.00 is the world average for papers of the same subfield, year and type.
The dot is this category, the solid tick is the median of all ranked journals and the dashed line is the world average.
Share of ranked journals in this category that are fully open access, so every paper is free to read. Hybrid journals, which sell subscriptions and open single papers for a fee, are not counted.
Median list price of the article processing charge, in US dollars, among ranked journals in this category that list a price above zero. Journals with a listed APC of $0 and journals with no known price are left out of this median. The At a glance table below gives a second median that includes the $0 prices.
Subfields of Medicine (42)
- Surgery980
- Pulmonary and Respiratory Medicine364
- Public Health, Environmental and Occupational Health316
- Cardiology and Cardiovascular Medicine289
- Infectious Diseases263
- Oncology243
- Epidemiology187
- Neurology175
- Radiology, Nuclear Medicine and Imaging161
- Physiology159
- Endocrinology, Diabetes and Metabolism157
- Psychiatry and Mental health144
- Pharmacology49
Show all 42 subfields
- Orthopedics and Sports Medicine125
- Ophthalmology100
- Pediatrics, Perinatology and Child Health100
- Dermatology92
- Obstetrics and Gynecology85
- Hematology83
- Rheumatology67
- Nephrology65
- Complementary and alternative medicine59
- Reproductive Medicine52
- Emergency Medicine42
- Geriatrics and Gerontology37
- Rehabilitation34
- Otorhinolaryngology33
- Hepatology30
- Pathology and Forensic Medicine29
- Immunology and Allergy26
- Critical Care and Intensive Care Medicine23
- Genetics19
- Anesthesiology and Pain Medicine14
- Urology12
- Health Informatics9
- Gastroenterology7
- Internal Medicine6
- Family Practice2
- Transplantation2
- Anatomy0
- Biochemistry0
- Microbiology0
49 ranked journals
Filters
Rank is the position by OJR within the list on screen; 1 is the highest. | OJR is field-normalized 3-year citation impact: 1.00 is the world average for papers of the same subfield, year and type, so values compare across fields. The badge is the journal’s quartile in this list. | Citations per paper over a two-year window, counted from OpenAlex. It is not field-normalized, so compare it only between journals of the same field. ▲ or ▼ is the change from 2023. This is OpenJournalRank’s own count, not Clarivate’s Journal Impact Factor. | Citable documents (articles, reviews and conference papers) published in 2021–2023, the window the 2024 OJR is computed on. A journal needs at least 30 to be ranked. | Share of the journal’s 2021–2023 papers that are free to read in any open-access form. The green OA tag next to a title marks a fully open-access journal. | List price of the article processing charge in US dollars. “$0 listed” means the listed price is zero; a dash means no price is listed. | The line is the journal’s OJR from 2015 to 2024. | Compare |
|---|---|---|---|---|---|---|---|
1Natural Product ReportsRoyal Society of Chemistry · United Kingdom | 3.49Q1 | 10.95 0.30 up from 2023 | 239 | 68% | — | ||
2Fungal Biology and BiotechnologyOABioMed Central · United Kingdom | 1.80Q1 | 4.50 1.39 down from 2023 | 59 | 100% | $2,590 | ||
3Journal of Cannabis ResearchOABioMed Central · United Kingdom | 1.61Q1 | 4.60 0.76 down from 2023 | 147 | 100% | $2,590 | ||
4Journal of Orthopaedic and Sports Physical TherapyAmerican Physical Therapy Association · United States | 1.61Q1 | 5.07 0.73 down from 2023 | 211 | 23% | — | ||
5Clinical PharmacokineticsAdis, Springer Healthcare · Switzerland | 1.57Q1 | 4.41 0.77 down from 2023 | 334 | 66% | $4,990 | ||
6Journal of PainElsevier BV · United States | 1.40Q1 | 3.56 1.07 down from 2023 | 543 | 99% | $4,180 | ||
7European Journal of PainWiley · United Kingdom | 1.35Q1 | 3.62 0.08 down from 2023 | 468 | 82% | $4,310 | ||
8Physical TherapyOxford University Press · United States | 1.33Q1 | 3.14 0.88 down from 2023 | 598 | 65% | $4,035 | ||
9Journal of physiotherapyOAElsevier BV · Netherlands | 1.32Q1 | 3.50 1.01 down from 2023 | 188 | 100% | $3,450 | ||
10Brazilian Journal of Physical TherapyElsevier BV · Brazil | 1.28Q1 | 3.71 0.23 up from 2023 | 170 | 19% | $3,000 | ||
11Medical Cannabis and CannabinoidsOAKarger Publishers · Switzerland | 1.28Q1 | 3.25 0.75 down from 2023 | 47 | 100% | $990 | ||
12Canadian Journal of PainOATaylor & Francis · United States | 1.23Q1 | 2.51 0.30 up from 2023 | 84 | 100% | $1,459 | ||
13Pharmacotherapy The Journal of Human Pharmacology and Drug TherapyWiley · United States | 1.21Q1 | 3.77 0.39 up from 2023 | 311 | 65% | $4,030 | ||
14Cannabis and Cannabinoid ResearchMary Ann Liebert, Inc. · United States | 1.18Q2 | 3.02 0.51 down from 2023 | 320 | 49% | — | ||
15BMC Pharmacology and ToxicologyOABioMed Central · United Kingdom | 1.13Q2 | 3.21 0.26 down from 2023 | 239 | 100% | $3,090 | ||
16Journal of Natural ProductsAmerican Chemical Society · United States | 1.08Q2 | 3.78 0.17 up from 2023 | 905 | 35% | $4,500 | ||
17Pain MedicineOxford University Press · United States | 1.07Q2 | 2.63 0.05 up from 2023 | 683 | 74% | $5,036 | ||
18Experimental and Clinical PsychopharmacologyAmerican Psychological Association · United States | 1.00Q2 | 2.24 0.46 down from 2023 | 267 | 53% | — | ||
19Musculoskeletal Science and PracticeElsevier BV · United Kingdom | 0.96Q2 | 2.40 0.18 down from 2023 | 402 | 54% | $3,500 | ||
20Hong Kong Physiotherapy JournalOAWorld Scientific · Netherlands | 0.81Q2 | 1.55 0.35 up from 2023 | 54 | 100% | — | ||
21The Journal of AntibioticsSpringer Nature · Japan | 0.80Q2 | 2.83 0.48 up from 2023 | 274 | 25% | $4,590 | ||
22Therapeutic Drug MonitoringLippincott Williams & Wilkins · United States | 0.76Q2 | 2.15 0.28 down from 2023 | 284 | 26% | — | ||
23WorkIOS Press · Netherlands | 0.74Q2 | 1.67 0.26 down from 2023 | 1,298 | 34% | $4,150 | ||
24Journal of Veterinary Pharmacology and TherapeuticsWiley · United Kingdom | 0.74Q2 | 1.80 0.06 up from 2023 | 195 | 55% | $4,520 | ||
25Scandinavian Journal of PainOAElsevier BV · Germany | 0.72Q2 | 2.16 0.26 up from 2023 | 223 | 100% | $2,260 | ||
26Journal of Manual & Manipulative TherapyTaylor & Francis · United Kingdom | 0.71Q3 | 1.97 0.04 down from 2023 | 124 | 98% | — | ||
27British Journal of PainSAGE Publishing · United Kingdom | 0.68Q3 | 1.84 0.30 up from 2023 | 142 | 100% | $4,150 | ||
28Chiropractic & Manual TherapiesOABioMed Central · United Kingdom | 0.65Q3 | 2.24 0.28 down from 2023 | 153 | 100% | $2,290 | ||
29Translational and Clinical PharmacologyOASouth Korea | 0.57Q3 | 1.95 0.72 up from 2023 | 68 | 100% | — | ||
30CannabisOAUnited States | 0.57Q3 | 1.26 0.07 down from 2023 | 69 | 100% | — | ||
31Bulletin of Faculty of Physical TherapyOASpringer Nature · Egypt | 0.57Q3 | 1.56 0.27 up from 2023 | 142 | 100% | $0 listed | ||
32Journal of Manipulative and Physiological TherapeuticsElsevier BV · United States | 0.55Q3 | 1.31 0.22 down from 2023 | 179 | 26% | $2,900 | ||
33Central Nervous System Agents in Medicinal ChemistryBentham Science Publishers · Netherlands | 0.50Q3 | 1.66 0.06 up from 2023 | 48 | 0% | — | ||
34Ozone Science and EngineeringTaylor & Francis · United States | 0.49Q3 | 1.58 0.85 down from 2023 | 130 | 22% | — | ||
35Journal of Chiropractic MedicineElsevier BV · United States | 0.48Q3 | 1.09 0.01 up from 2023 | 111 | 83% | $3,300 | ||
36European Journal of PhysiotherapyTaylor & Francis · United States | 0.46Q3 | 1.26 0.29 down from 2023 | 108 | 49% | — | ||
37International journal of medicinal mushroomsBegell House · United States | 0.46Q3 | 1.48 0.61 down from 2023 | 239 | 5% | — | ||
38International journal of osteopathic medicineElsevier BV · United Kingdom | 0.40Q4 | 1.39 0.08 down from 2023 | 122 | 46% | $2,740 | ||
39Der SchmerzSpringer Science+Business Media · Germany | 0.37Q4 | 0.80 0.24 down from 2023 | 176 | 50% | $3,390 | ||
40Current Drug SafetyBentham Science Publishers · Netherlands | 0.36Q4 | 1.11 0.21 up from 2023 | 203 | 12% | — | ||
41Current Enzyme InhibitionBentham Science Publishers · Netherlands | 0.27Q4 | 0.79 0.33 up from 2023 | 61 | 0% | — | ||
42Physiotherapy QuarterlyOATermedia Publishing House · Poland | 0.27Q4 | 0.72 0.20 up from 2023 | 175 | 100% | — | ||
43Humboldt Journal of Social RelationsPublisher not listed | 0.20Q4 | 0.31 0.39 down from 2023 | 65 | 11% | — | ||
44Integrative Medicine ReportsOAMary Ann Liebert, Inc. | 0.16Q4 | 0.41 0.07 down from 2023 | 46 | 100% | — | ||
45Indian Journal of Physiotherapy and Occupational Therapy - An International JournalInstitute of Medico-legal Publications Private Limited · India | 0.15Q4 | 0.22 0.13 down from 2023 | 246 | 99% | — | ||
46Physiotherapy Practice and ResearchIOS Press · Netherlands | 0.13Q4 | 0.30 0.14 down from 2023 | 90 | 32% | $4,150 | ||
47Pharmacy & Pharmacology International JournalMedCrave Group · United States | 0.12Q4 | 0.50 0.13 up from 2023 | 99 | 59% | — | ||
48Chronic Pain & ManagementOAUnited States | 0.12Q4 | 0.21 0.21 up from 2023 | 31 | 100% | — | ||
49AMA guides newsletterPublisher not listed | 0.02Q4 | 0.06 0.08 down from 2023 | 57 | 0% | — |
Subfields of Medicine, with Pharmacology highlighted.
- Surgery980
- Pulmonary and Respiratory Medicine364
- Public Health, Environmental and Occupational Health316
- Cardiology and Cardiovascular Medicine289
- Infectious Diseases263
- Oncology243
- Epidemiology187
- Neurology175
- Radiology, Nuclear Medicine and Imaging161
- Physiology159
- Endocrinology, Diabetes and Metabolism157
- Psychiatry and Mental health144
- Orthopedics and Sports Medicine125
- Ophthalmology100
- Pediatrics, Perinatology and Child Health100
- Dermatology92
- Obstetrics and Gynecology85
- Hematology83
- Rheumatology67
- Nephrology65
- Complementary and alternative medicine59
- Reproductive Medicine52
- Pharmacology49
- Emergency Medicine42
- Geriatrics and Gerontology37
- Rehabilitation34
- Otorhinolaryngology33
- Hepatology30
- Pathology and Forensic Medicine29
- Immunology and Allergy26
- Critical Care and Intensive Care Medicine23
- Genetics19
- Anesthesiology and Pain Medicine14
- Urology12
- Health Informatics9
- Gastroenterology7
- Internal Medicine6
- Family Practice2
- Transplantation2
- Anatomy0
- Biochemistry0
- Microbiology0
Journals
Citations made in 2024. Corpus-wide, 87.1% of core-journal articles and reviews published that year have at least one matched reference; the share varies by journal and field.
11 additional Pharmacology journals with metrics are unranked under this release’s eligibility rules: a journal needs at least 30 citable documents in 2021–2023, at least 80% of them with a subfield, and a positive world-average expectation. Ranks are within the whole category; filters hide rows without re-ranking. OJR excludes self-citations.
At a glance
Indicator year: 2024. Publication window: 2021–2023. How these summaries are calculated
- Ranked journals
- 49
- Window papers (baseline)
- 70,967 +8.6% from indicator year 2021
- Median OJR
- 0.7243 +9.4% from indicator year 2021
- Rising journals (2025)
- 1
Window papers are the baseline paper population: citable papers (articles, reviews and conference papers) from 2021–2023 in all journals of the world-average baseline, including non-core journals, counted by each paper’s own subfield. They are not the papers of the ranked journals alone.
| Measure | Year series | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Ranked journals | 22 | 24 | 26 | 27 | 30 | 31 | 29 | 33 | 32 | 34 | 35 | 36 | 38 | 40 | 43 | 42 | 44 | 46 | 51 | 54 | 53 | 54 | 51 | 52 | 49 | 49 | |
| Window papers (baseline) | 19,603 | 22,467 | 24,630 | 27,412 | 29,324 | 32,358 | 35,691 | 39,107 | 42,145 | 45,380 | 48,527 | 52,153 | 54,359 | 55,921 | 57,834 | 58,910 | 59,488 | 58,462 | 57,882 | 58,590 | 61,076 | 65,359 | 69,176 | 70,919 | 70,967 | 72,738 | |
| Median OJR | 0.50 | 0.59 | 0.56 | 0.672 | 0.51 | 0.62 | 0.715 | 0.667 | 0.7235 | 0.80 | 0.892 | 0.91 | 1.001 | 0.891 | 0.7936 | 0.7943 | 0.77 | 0.76 | 0.65 | 0.644 | 0.642 | 0.662 | 0.75 | 0.659 | 0.7243 | 0.73 |
How to read these rankings
- OJR, the OpenJournalRank Indicator
- A field-normalized 3-year citation impact, computed from OpenAlex with the NCI3 method. It divides the citations a journal’s papers received by the world average for papers of the same subfield, year and type, so 1.00 is the world average and 2.00 means twice as many citations as expected. Because it is normalized, it can be compared across fields. Read the methodology
- Quartiles
- Q1 to Q4 split the ranked journals of the list you are viewing into four equal groups by OJR. A journal’s quartile depends on the list: the same journal can be Q1 in its subfield and Q2 among all journals.
- Impact factor (2-year)
- Citations per paper over a two-year window, counted from OpenAlex. It is easy to compare with familiar impact factors but is not field-normalized, so compare it only within a field. It is not Clarivate’s Journal Impact Factor. Why it differs from the Journal Impact Factor
- Rank ranges
- Each rank in the latest year carries a likely range from 1,000 resamples of the journal’s papers. Where two journals’ ranges overlap, the data cannot tell them apart, so treat neighbouring ranks as ties.